-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication
April 26, 2022
Recommendations made by the USPSTF are independent of the U.S. government…
-
digital.ahrq.gov/sites/default/files/docs/citation/u18hs024849-blumenfeld-final-report-2020.pdf
January 01, 2020 - The Patient-Centered Clinical Decision Support Learning Network: Improving the Dissemination of PCOR in Patient-Centered Clinical Decision Support - Final Report
1
Final Report
The Patient-Centered Clinical Decision
Support Learning Network: Improving…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
September 28, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication
September 28, 2021
Recommendations made by the USPSTF are indepe…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/osteoporosis-screening-2002
September 17, 2002 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Osteoporosis: Screening, 2002
September 17, 2002
Recommendations made by the USPSTF are independent of the U.S. government. They should not be const…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - Tobacco Use and Help With Quitting Among Adolescents
Tobacco Use and Help With Quitting Among
Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Tobacco Use and Help With Quitting Among Adolescents
1.B. Measure Number
0090
1.C. Measure Description
Please provide a non-technical description …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-fullreport.pdf
June 01, 2018 - Continuity of Insurance: Duration of First Observed Enrollment
1
Continuity of Insurance: Duration of First Observed
Enrollment
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Duration of First Observed Enrollment
1.B. Measure Number
0156
1.C. Measure Description
Please …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-fullreport.pdf
May 23, 2018 - Continuity of Insurance: Informed Participation
1
Continuity of Insurance: Informed Participation
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Informed Participation
1.B. Measure Number
0153
1.C. Measure Description
Please provide a non-technical description of the me…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-fullreport.pdf
September 01, 2018 - Continuity of Insurance: Coverage Presumed Ineligible
1
Continuity of Insurance: Coverage Presumed
Ineligible
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Coverage Presumed Ineligible
1.B. Measure Number
0155
1.C. Measure Description
Please provide a non-technical d…
-
qualityindicators.ahrq.gov/Downloads/Resources/Publications/FullListPublications-508.pdf
October 09, 2024 - AHRQ Quality Indicator-related Publications
AHRQ Quality Indicator-related Publications
The list below presents selected articles from 2002 through 2024 that focus on the use
of AHRQ QIs for quality improvement purposes.
2024
Alizadeh, Nasrin, Kimia Vahdat, Sara Shashaani, Julie L. Swann, and
Osman Y. Öz…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - Assessing the Availability of the Preconception Component of High-Risk Obstetrical Services by Estimating the Use of Teratogenic Medications Before and During Pregnancy
1
Assessing the Availability of the Preconception
Component of High-Risk Obstetrical Services by
Estimating the Use of Teratogenic Medications B…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary35/lung-cancer-screening-2004
May 15, 2004 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Evidence Summary
Lung Cancer: Screening, May 2004
May 15, 2004
Recommendations made by the USPSTF are independent of the U.S. government. They should not…
-
www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/colorectal-cancer-screening-june-2016
June 15, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Modeling Study
Colorectal Cancer: Screening
June 15, 2016
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construe…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2Wc3FRHpVDPX2jT_WzjEXX
July 31, 2020 - Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation
Screening for Colorectal Cancer
US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
IMPORTANCE Colorectal cancer is the third leading cause of cancer death for both men and
women, with an estima…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2kM7LY6ccceVo8bmdUXhYm
September 01, 2002 - Screening for Postmenopausal Osteoporosis: A Summary of the Evidence
Epidemiology
Half of all postmenopausal women will have an
osteoporosis-related fracture during their lives,
including one-quarter who will develop a vertebral
deformity1 and 15% who will suffer a hip fracture.2
Hip fractures are associated with h…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary44/sexually-transmitted-infections-behavioral-counseling-2008
October 15, 2008 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Evidence Summary
Sexually Transmitted Infections: Behavioral Counseling
October 15, 2008
Recommendations made by the USPSTF are independent of the U.S. gover…
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-evaluation-summary-report-p233201500023I.pdf
March 23, 2022 - Evaluation of the Agency for Healthcare Research and Quality Patient-Centered Outcomes Research Clinical Decision Support Initiative: Findings and Recommendations for Future Initiatives
Summary Report
Evaluation of the Agency
for Healthcare Research
and Quality Patient-
Centered Outcomes
Research Clinical Decisi…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
January 01, 2014 - 1
Comparative Effectiveness Review
Number 124
Meditation Programs for Psychological
Stress and Well-Being
Executive Summary
Introduction
Definition of Meditation
The National Center for Complementary
and Alternative Medicine defines
meditation as a “mind-body” method.
This category of complementary
and …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
April 01, 2016 - Treatment Resistant Depression Surveillance FINAL
AHRQ Systematic Review
Surveillance Program
CER #33: …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-088-fullreport.pdf
January 05, 2017 - Stratified measures can be used internally or more broadly by the
medical community to better target
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-089-fullreport.pdf
January 30, 2017 - Stratified measures can be used
internally or more broadly by the medical community to target interventions